Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-progressive Congenital Ataxia - Advancing Diagnosis to Enhance Chances for Targeted Therapy

NCT07421219 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT07421219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07421219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-progressive Congenital Ataxia - Advancing Diagnosis to Enhance Chances for Targeted Therapy
Lead sponsor
Vastra Gotaland Region
Phase
Observational
Overall status
Recruiting
Start date
May 15, 2026
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

ataxic cerebral palsy, non-progressive congenital ataxia